JPWO2020117526A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020117526A5 JPWO2020117526A5 JP2021530163A JP2021530163A JPWO2020117526A5 JP WO2020117526 A5 JPWO2020117526 A5 JP WO2020117526A5 JP 2021530163 A JP2021530163 A JP 2021530163A JP 2021530163 A JP2021530163 A JP 2021530163A JP WO2020117526 A5 JPWO2020117526 A5 JP WO2020117526A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- derived
- receptor
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims 62
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims 22
- 206010028980 Neoplasm Diseases 0.000 claims 21
- 239000000427 antigen Substances 0.000 claims 17
- 102000036639 antigens Human genes 0.000 claims 17
- 108091007433 antigens Proteins 0.000 claims 17
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims 15
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims 15
- 102100029193 Low affinity immunoglobulin gamma Fc region receptor III-A Human genes 0.000 claims 15
- 102000005962 receptors Human genes 0.000 claims 15
- 108020003175 receptors Proteins 0.000 claims 15
- -1 41BBL Proteins 0.000 claims 14
- 102000040430 polynucleotide Human genes 0.000 claims 13
- 108091033319 polynucleotide Proteins 0.000 claims 13
- 239000002157 polynucleotide Substances 0.000 claims 12
- 108090000172 Interleukin-15 Proteins 0.000 claims 10
- 102000003812 Interleukin-15 Human genes 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims 9
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims 9
- 108091008874 T cell receptors Proteins 0.000 claims 9
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 9
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 8
- 102100031940 Epithelial cell adhesion molecule Human genes 0.000 claims 8
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims 8
- 101001109503 Homo sapiens NKG2-C type II integral membrane protein Proteins 0.000 claims 8
- 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 claims 8
- 102000017578 LAG3 Human genes 0.000 claims 8
- 102100022683 NKG2-C type II integral membrane protein Human genes 0.000 claims 8
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims 8
- 101000971513 Homo sapiens Natural killer cells antigen CD94 Proteins 0.000 claims 7
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims 7
- 102100021462 Natural killer cells antigen CD94 Human genes 0.000 claims 7
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims 7
- 102000004127 Cytokines Human genes 0.000 claims 6
- 108090000695 Cytokines Proteins 0.000 claims 6
- 101100382122 Homo sapiens CIITA gene Proteins 0.000 claims 6
- 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims 6
- 101000809875 Homo sapiens TYRO protein tyrosine kinase-binding protein Proteins 0.000 claims 6
- 101150069255 KLRC1 gene Proteins 0.000 claims 6
- 102100026371 MHC class II transactivator Human genes 0.000 claims 6
- 108700002010 MHC class II transactivator Proteins 0.000 claims 6
- 101100404845 Macaca mulatta NKG2A gene Proteins 0.000 claims 6
- 102100022682 NKG2-A/NKG2-B type II integral membrane protein Human genes 0.000 claims 6
- 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims 6
- 102100038717 TYRO protein tyrosine kinase-binding protein Human genes 0.000 claims 6
- 239000012642 immune effector Substances 0.000 claims 6
- 229940121354 immunomodulator Drugs 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims 6
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims 5
- 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims 5
- 108010021064 CTLA-4 Antigen Proteins 0.000 claims 5
- 229940045513 CTLA4 antagonist Drugs 0.000 claims 5
- 102100028970 HLA class I histocompatibility antigen, alpha chain E Human genes 0.000 claims 5
- 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims 5
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims 5
- 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims 5
- 101000986085 Homo sapiens HLA class I histocompatibility antigen, alpha chain E Proteins 0.000 claims 5
- 101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 claims 5
- 101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 claims 5
- 101150030213 Lag3 gene Proteins 0.000 claims 5
- 102100032913 Leukocyte surface antigen CD47 Human genes 0.000 claims 5
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims 5
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims 5
- 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 claims 5
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims 5
- 108020001507 fusion proteins Proteins 0.000 claims 5
- 102000037865 fusion proteins Human genes 0.000 claims 5
- 210000002865 immune cell Anatomy 0.000 claims 5
- 238000003780 insertion Methods 0.000 claims 5
- 230000037431 insertion Effects 0.000 claims 5
- 239000010445 mica Substances 0.000 claims 5
- 229910052618 mica group Inorganic materials 0.000 claims 5
- RJBDSRWGVYNDHL-XNJNKMBASA-N (2S,4R,5S,6S)-2-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2R,3S)-3-hydroxy-2-(octadecanoylamino)octadec-4-enoxy]oxan-3-yl]oxy-3-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-5-amino-6-[(1S,2R)-2-[(2S,4R,5S,6S)-5-amino-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-1,3-dihydroxypropyl]-4-hydroxyoxane-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3NC(C)=O)[C@H](O[C@@]3(C[C@@H](O)[C@H](N)[C@H](O3)[C@H](O)[C@@H](CO)O[C@@]3(C[C@@H](O)[C@H](N)[C@H](O3)[C@H](O)[C@H](O)CO)C(O)=O)C(O)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@@H](O)\C=C\CCCCCCCCCCCCC RJBDSRWGVYNDHL-XNJNKMBASA-N 0.000 claims 4
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims 4
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims 4
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 claims 4
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims 4
- 108010009685 Cholinergic Receptors Proteins 0.000 claims 4
- 241000701022 Cytomegalovirus Species 0.000 claims 4
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims 4
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 4
- 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 claims 4
- 108010024164 HLA-G Antigens Proteins 0.000 claims 4
- 101000920667 Homo sapiens Epithelial cell adhesion molecule Proteins 0.000 claims 4
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims 4
- 101001005728 Homo sapiens Melanoma-associated antigen 1 Proteins 0.000 claims 4
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims 4
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 4
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims 4
- 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 claims 4
- 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 claims 4
- 101710112634 Interleukin-13 receptor subunit alpha-2 Proteins 0.000 claims 4
- 102100025050 Melanoma-associated antigen 1 Human genes 0.000 claims 4
- 102000003735 Mesothelin Human genes 0.000 claims 4
- 108090000015 Mesothelin Proteins 0.000 claims 4
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims 4
- 108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 claims 4
- 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 claims 4
- 102000036673 PRAME Human genes 0.000 claims 4
- 108060006580 PRAME Proteins 0.000 claims 4
- 101710120463 Prostate stem cell antigen Proteins 0.000 claims 4
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims 4
- 101001039269 Rattus norvegicus Glycine N-methyltransferase Proteins 0.000 claims 4
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 4
- 102000034337 acetylcholine receptors Human genes 0.000 claims 4
- 229960003852 atezolizumab Drugs 0.000 claims 4
- 230000007812 deficiency Effects 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 239000012636 effector Substances 0.000 claims 4
- 229960003301 nivolumab Drugs 0.000 claims 4
- 229960002621 pembrolizumab Drugs 0.000 claims 4
- 229920001184 polypeptide Polymers 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 230000011664 signaling Effects 0.000 claims 4
- 230000004936 stimulating effect Effects 0.000 claims 4
- 108010082808 4-1BB Ligand Proteins 0.000 claims 3
- 102100022464 5'-nucleotidase Human genes 0.000 claims 3
- 102100026882 Alpha-synuclein Human genes 0.000 claims 3
- 102100030346 Antigen peptide transporter 1 Human genes 0.000 claims 3
- 102100030343 Antigen peptide transporter 2 Human genes 0.000 claims 3
- 101000840545 Bacillus thuringiensis L-isoleucine-4-hydroxylase Proteins 0.000 claims 3
- 102100027314 Beta-2-microglobulin Human genes 0.000 claims 3
- 102100024263 CD160 antigen Human genes 0.000 claims 3
- 108010062802 CD66 antigens Proteins 0.000 claims 3
- 108091033409 CRISPR Proteins 0.000 claims 3
- 238000010354 CRISPR gene editing Methods 0.000 claims 3
- 101100463133 Caenorhabditis elegans pdl-1 gene Proteins 0.000 claims 3
- 102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 claims 3
- 102100021396 Cell surface glycoprotein CD200 receptor 1 Human genes 0.000 claims 3
- 101710093674 Cyclic nucleotide-gated cation channel beta-1 Proteins 0.000 claims 3
- 102100020986 DNA-binding protein RFX5 Human genes 0.000 claims 3
- 102100021044 DNA-binding protein RFXANK Human genes 0.000 claims 3
- 102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 claims 3
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 3
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims 3
- 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 claims 3
- 101000937544 Homo sapiens Beta-2-microglobulin Proteins 0.000 claims 3
- 101000761938 Homo sapiens CD160 antigen Proteins 0.000 claims 3
- 101000969553 Homo sapiens Cell surface glycoprotein CD200 receptor 1 Proteins 0.000 claims 3
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims 3
- 101001075432 Homo sapiens DNA-binding protein RFX5 Proteins 0.000 claims 3
- 101001075464 Homo sapiens DNA-binding protein RFXANK Proteins 0.000 claims 3
- 101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 claims 3
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 3
- 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 claims 3
- 101001037256 Homo sapiens Indoleamine 2,3-dioxygenase 1 Proteins 0.000 claims 3
- 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims 3
- 101001109698 Homo sapiens Nuclear receptor subfamily 4 group A member 2 Proteins 0.000 claims 3
- 101001098352 Homo sapiens OX-2 membrane glycoprotein Proteins 0.000 claims 3
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims 3
- 101000979565 Homo sapiens Protein NLRC5 Proteins 0.000 claims 3
- 101001075466 Homo sapiens Regulatory factor X-associated protein Proteins 0.000 claims 3
- 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 claims 3
- 101000687808 Homo sapiens Suppressor of cytokine signaling 2 Proteins 0.000 claims 3
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims 3
- 101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 claims 3
- 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 claims 3
- 101000979190 Homo sapiens Transcription factor MafB Proteins 0.000 claims 3
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims 3
- 101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 claims 3
- 206010062016 Immunosuppression Diseases 0.000 claims 3
- 102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 claims 3
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 claims 3
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 claims 3
- 108010065805 Interleukin-12 Proteins 0.000 claims 3
- 102000013462 Interleukin-12 Human genes 0.000 claims 3
- 102000000704 Interleukin-7 Human genes 0.000 claims 3
- 108010002586 Interleukin-7 Proteins 0.000 claims 3
- 108010043610 KIR Receptors Proteins 0.000 claims 3
- 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 claims 3
- 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 claims 3
- 101710150918 Macrophage colony-stimulating factor 1 receptor Proteins 0.000 claims 3
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims 3
- 108010023335 Member 2 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 claims 3
- 102100022676 Nuclear receptor subfamily 4 group A member 2 Human genes 0.000 claims 3
- 102100037589 OX-2 membrane glycoprotein Human genes 0.000 claims 3
- 102100035591 POU domain, class 2, transcription factor 2 Human genes 0.000 claims 3
- 101710084411 POU domain, class 2, transcription factor 2 Proteins 0.000 claims 3
- 102100023432 Protein NLRC5 Human genes 0.000 claims 3
- 101150066717 Rara gene Proteins 0.000 claims 3
- 102100021043 Regulatory factor X-associated protein Human genes 0.000 claims 3
- 101001037255 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Indoleamine 2,3-dioxygenase Proteins 0.000 claims 3
- 102100024784 Suppressor of cytokine signaling 2 Human genes 0.000 claims 3
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims 3
- 102100035268 T-cell surface protein tactile Human genes 0.000 claims 3
- 101800000849 Tachykinin-associated peptide 2 Proteins 0.000 claims 3
- 102100028082 Tapasin Human genes 0.000 claims 3
- 102100024324 Toll-like receptor 3 Human genes 0.000 claims 3
- 102100023234 Transcription factor MafB Human genes 0.000 claims 3
- 102100025946 Transforming growth factor beta activator LRRC32 Human genes 0.000 claims 3
- 101710169732 Transforming growth factor beta activator LRRC32 Proteins 0.000 claims 3
- 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 claims 3
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims 3
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims 3
- 102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 claims 3
- 102100022748 Wilms tumor protein Human genes 0.000 claims 3
- 101710127857 Wilms tumor protein Proteins 0.000 claims 3
- 239000005557 antagonist Substances 0.000 claims 3
- 229950002916 avelumab Drugs 0.000 claims 3
- 210000000349 chromosome Anatomy 0.000 claims 3
- 230000004186 co-expression Effects 0.000 claims 3
- 210000004700 fetal blood Anatomy 0.000 claims 3
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 claims 3
- 101150022222 foxp1 gene Proteins 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 238000003881 globally optimized alternating phase rectangular pulse Methods 0.000 claims 3
- 230000001506 immunosuppresive effect Effects 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 108010025001 leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 claims 3
- 210000000822 natural killer cell Anatomy 0.000 claims 3
- 210000005259 peripheral blood Anatomy 0.000 claims 3
- 239000011886 peripheral blood Substances 0.000 claims 3
- 108010059434 tapasin Proteins 0.000 claims 3
- 210000001519 tissue Anatomy 0.000 claims 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 2
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims 2
- 102100026402 Adhesion G protein-coupled receptor E2 Human genes 0.000 claims 2
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims 2
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims 2
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims 2
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 2
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 claims 2
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 claims 2
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims 2
- 102100026094 C-type lectin domain family 12 member A Human genes 0.000 claims 2
- 102000007269 CA-125 Antigen Human genes 0.000 claims 2
- 108010008629 CA-125 Antigen Proteins 0.000 claims 2
- 108700012439 CA9 Proteins 0.000 claims 2
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims 2
- 102100027207 CD27 antigen Human genes 0.000 claims 2
- 102100032912 CD44 antigen Human genes 0.000 claims 2
- 102100025221 CD70 antigen Human genes 0.000 claims 2
- 102000024905 CD99 Human genes 0.000 claims 2
- 108060001253 CD99 Proteins 0.000 claims 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims 2
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 claims 2
- 102100024423 Carbonic anhydrase 9 Human genes 0.000 claims 2
- 102100039061 Cytokine receptor common subunit beta Human genes 0.000 claims 2
- 102000001301 EGF receptor Human genes 0.000 claims 2
- 108010087819 Fc receptors Proteins 0.000 claims 2
- 102000009109 Fc receptors Human genes 0.000 claims 2
- 102000010451 Folate receptor alpha Human genes 0.000 claims 2
- 108050001931 Folate receptor alpha Proteins 0.000 claims 2
- 102000003886 Glycoproteins Human genes 0.000 claims 2
- 108090000288 Glycoproteins Proteins 0.000 claims 2
- 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 claims 2
- 102100029360 Hematopoietic cell signal transducer Human genes 0.000 claims 2
- 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 claims 2
- 101000718211 Homo sapiens Adhesion G protein-coupled receptor E2 Proteins 0.000 claims 2
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 2
- 101000912622 Homo sapiens C-type lectin domain family 12 member A Proteins 0.000 claims 2
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims 2
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims 2
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims 2
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims 2
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 claims 2
- 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 claims 2
- 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 claims 2
- 101000990188 Homo sapiens Hematopoietic cell signal transducer Proteins 0.000 claims 2
- 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 claims 2
- 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 claims 2
- 101001078143 Homo sapiens Integrin alpha-IIb Proteins 0.000 claims 2
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims 2
- 101000984189 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 2 Proteins 0.000 claims 2
- 101000589305 Homo sapiens Natural cytotoxicity triggering receptor 2 Proteins 0.000 claims 2
- 101001023712 Homo sapiens Nectin-3 Proteins 0.000 claims 2
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims 2
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims 2
- 101000874179 Homo sapiens Syndecan-1 Proteins 0.000 claims 2
- 101000662902 Homo sapiens T cell receptor beta constant 2 Proteins 0.000 claims 2
- 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 claims 2
- 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 claims 2
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims 2
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims 2
- 102100032816 Integrin alpha-6 Human genes 0.000 claims 2
- 102100025306 Integrin alpha-IIb Human genes 0.000 claims 2
- 102100030704 Interleukin-21 Human genes 0.000 claims 2
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims 2
- 102100025583 Leukocyte immunoglobulin-like receptor subfamily B member 2 Human genes 0.000 claims 2
- 108010008707 Mucin-1 Proteins 0.000 claims 2
- 102000007298 Mucin-1 Human genes 0.000 claims 2
- 101100346932 Mus musculus Muc1 gene Proteins 0.000 claims 2
- 108010004217 Natural Cytotoxicity Triggering Receptor 1 Proteins 0.000 claims 2
- 108010004222 Natural Cytotoxicity Triggering Receptor 3 Proteins 0.000 claims 2
- 102100032870 Natural cytotoxicity triggering receptor 1 Human genes 0.000 claims 2
- 102100032851 Natural cytotoxicity triggering receptor 2 Human genes 0.000 claims 2
- 102100032852 Natural cytotoxicity triggering receptor 3 Human genes 0.000 claims 2
- 102100035487 Nectin-3 Human genes 0.000 claims 2
- 102000003729 Neprilysin Human genes 0.000 claims 2
- 108090000028 Neprilysin Proteins 0.000 claims 2
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims 2
- 108091000080 Phosphotransferase Proteins 0.000 claims 2
- 102100040120 Prominin-1 Human genes 0.000 claims 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims 2
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims 2
- 229940100514 Syk tyrosine kinase inhibitor Drugs 0.000 claims 2
- 102100035721 Syndecan-1 Human genes 0.000 claims 2
- 102100037298 T cell receptor beta constant 2 Human genes 0.000 claims 2
- 102100027208 T-cell antigen CD7 Human genes 0.000 claims 2
- 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims 2
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims 2
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims 2
- 101800000385 Transmembrane protein Proteins 0.000 claims 2
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims 2
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims 2
- 206010064390 Tumour invasion Diseases 0.000 claims 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 2
- SRHNADOZAAWYLV-XLMUYGLTSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](NC(C)=O)[C@H](O)O[C@@H]2CO)O[C@H]2[C@H]([C@H](O)[C@H](O)[C@H](C)O2)O)O[C@H](CO)[C@H](O)[C@@H]1O SRHNADOZAAWYLV-XLMUYGLTSA-N 0.000 claims 2
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 claims 2
- 229960000106 biosimilars Drugs 0.000 claims 2
- 230000000981 bystander Effects 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 230000009400 cancer invasion Effects 0.000 claims 2
- 230000003013 cytotoxicity Effects 0.000 claims 2
- 231100000135 cytotoxicity Toxicity 0.000 claims 2
- 229960002204 daratumumab Drugs 0.000 claims 2
- 229950009791 durvalumab Drugs 0.000 claims 2
- 108010087914 epidermal growth factor receptor VIII Proteins 0.000 claims 2
- 230000001605 fetal effect Effects 0.000 claims 2
- 150000002270 gangliosides Chemical class 0.000 claims 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 2
- 102000006495 integrins Human genes 0.000 claims 2
- 108010044426 integrins Proteins 0.000 claims 2
- 108010074108 interleukin-21 Proteins 0.000 claims 2
- 230000003834 intracellular effect Effects 0.000 claims 2
- 229960005386 ipilimumab Drugs 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 229950001907 monalizumab Drugs 0.000 claims 2
- 244000052769 pathogen Species 0.000 claims 2
- 230000001717 pathogenic effect Effects 0.000 claims 2
- 230000002688 persistence Effects 0.000 claims 2
- 102000020233 phosphotransferase Human genes 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 230000004083 survival effect Effects 0.000 claims 2
- 230000008685 targeting Effects 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 102100023990 60S ribosomal protein L17 Human genes 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 1
- 108091032955 Bacterial small RNA Proteins 0.000 claims 1
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims 1
- 102100024210 CD166 antigen Human genes 0.000 claims 1
- 102100038077 CD226 antigen Human genes 0.000 claims 1
- 101150013553 CD40 gene Proteins 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 108010043471 Core Binding Factor Alpha 2 Subunit Proteins 0.000 claims 1
- 241000255925 Diptera Species 0.000 claims 1
- 102000012804 EPCAM Human genes 0.000 claims 1
- 101150084967 EPCAM gene Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims 1
- 206010066476 Haematological malignancy Diseases 0.000 claims 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 1
- 101000980840 Homo sapiens CD166 antigen Proteins 0.000 claims 1
- 101000884298 Homo sapiens CD226 antigen Proteins 0.000 claims 1
- 101000945331 Homo sapiens Killer cell immunoglobulin-like receptor 2DL4 Proteins 0.000 claims 1
- 101000945340 Homo sapiens Killer cell immunoglobulin-like receptor 2DS1 Proteins 0.000 claims 1
- 101001000998 Homo sapiens Protein phosphatase 1 regulatory subunit 12C Proteins 0.000 claims 1
- 101000713322 Homo sapiens SAP30-binding protein Proteins 0.000 claims 1
- 101000633778 Homo sapiens SLAM family member 5 Proteins 0.000 claims 1
- 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 claims 1
- 102000026633 IL6 Human genes 0.000 claims 1
- 102000003814 Interleukin-10 Human genes 0.000 claims 1
- 108090000174 Interleukin-10 Proteins 0.000 claims 1
- 102000003815 Interleukin-11 Human genes 0.000 claims 1
- 108090000177 Interleukin-11 Proteins 0.000 claims 1
- 102000003810 Interleukin-18 Human genes 0.000 claims 1
- 108090000171 Interleukin-18 Proteins 0.000 claims 1
- 102000000588 Interleukin-2 Human genes 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 102000004388 Interleukin-4 Human genes 0.000 claims 1
- 108090000978 Interleukin-4 Proteins 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 102000000585 Interleukin-9 Human genes 0.000 claims 1
- 108010002335 Interleukin-9 Proteins 0.000 claims 1
- 102100033633 Killer cell immunoglobulin-like receptor 2DL4 Human genes 0.000 claims 1
- 102100033631 Killer cell immunoglobulin-like receptor 2DS1 Human genes 0.000 claims 1
- 101710163270 Nuclease Proteins 0.000 claims 1
- 102100035620 Protein phosphatase 1 regulatory subunit 12C Human genes 0.000 claims 1
- 102100023606 Retinoic acid receptor alpha Human genes 0.000 claims 1
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 claims 1
- 102100036909 SAP30-binding protein Human genes 0.000 claims 1
- 102100029216 SLAM family member 5 Human genes 0.000 claims 1
- 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 claims 1
- 210000000173 T-lymphoid precursor cell Anatomy 0.000 claims 1
- 101150057140 TACSTD1 gene Proteins 0.000 claims 1
- 238000010459 TALEN Methods 0.000 claims 1
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 claims 1
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 208000008383 Wilms tumor Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229960000548 alemtuzumab Drugs 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 210000000601 blood cell Anatomy 0.000 claims 1
- 210000003850 cellular structure Anatomy 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 229960004497 dinutuximab Drugs 0.000 claims 1
- 229960004137 elotuzumab Drugs 0.000 claims 1
- 230000014509 gene expression Effects 0.000 claims 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 230000003394 haemopoietic effect Effects 0.000 claims 1
- 239000000710 homodimer Substances 0.000 claims 1
- 230000006801 homologous recombination Effects 0.000 claims 1
- 238000002744 homologous recombination Methods 0.000 claims 1
- 229940124622 immune-modulator drug Drugs 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 229950007752 isatuximab Drugs 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 239000003226 mitogen Substances 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 229960003347 obinutuzumab Drugs 0.000 claims 1
- 229960002450 ofatumumab Drugs 0.000 claims 1
- 229960002087 pertuzumab Drugs 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 210000004986 primary T-cell Anatomy 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- 108090000064 retinoic acid receptors Proteins 0.000 claims 1
- 102000003702 retinoic acid receptors Human genes 0.000 claims 1
- 108091008726 retinoic acid receptors α Proteins 0.000 claims 1
- 108091035539 telomere Proteins 0.000 claims 1
- 102000055501 telomere Human genes 0.000 claims 1
- 210000003411 telomere Anatomy 0.000 claims 1
- 230000002381 testicular Effects 0.000 claims 1
- 229960000575 trastuzumab Drugs 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N tryptophan Chemical compound C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- 229950000815 veltuzumab Drugs 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025018442A JP2025072543A (ja) | 2018-12-02 | 2025-02-06 | 増強されたｉＰＳＣ派生エフェクター細胞を使用した免疫療法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862774278P | 2018-12-02 | 2018-12-02 | |
| US62/774,278 | 2018-12-02 | ||
| PCT/US2019/063024 WO2020117526A1 (en) | 2018-12-02 | 2019-11-25 | IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025018442A Division JP2025072543A (ja) | 2018-12-02 | 2025-02-06 | 増強されたｉＰＳＣ派生エフェクター細胞を使用した免疫療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022510207A JP2022510207A (ja) | 2022-01-26 |
| JPWO2020117526A5 true JPWO2020117526A5 (https=) | 2022-12-12 |
| JP2022510207A5 JP2022510207A5 (https=) | 2022-12-12 |
Family
ID=70974390
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530163A Pending JP2022510207A (ja) | 2018-12-02 | 2019-11-25 | 増強されたｉＰＳＣ派生エフェクター細胞を使用した免疫療法 |
| JP2025018442A Pending JP2025072543A (ja) | 2018-12-02 | 2025-02-06 | 増強されたｉＰＳＣ派生エフェクター細胞を使用した免疫療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025018442A Pending JP2025072543A (ja) | 2018-12-02 | 2025-02-06 | 増強されたｉＰＳＣ派生エフェクター細胞を使用した免疫療法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12435123B2 (https=) |
| EP (1) | EP3891177A4 (https=) |
| JP (2) | JP2022510207A (https=) |
| KR (1) | KR102943217B1 (https=) |
| CN (1) | CN113166232A (https=) |
| AU (1) | AU2019392265A1 (https=) |
| BR (1) | BR112021010331A2 (https=) |
| CA (1) | CA3121128A1 (https=) |
| IL (1) | IL283607A (https=) |
| MX (1) | MX2021006194A (https=) |
| SG (1) | SG11202105480WA (https=) |
| WO (1) | WO2020117526A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021292695A1 (en) * | 2020-06-19 | 2023-02-02 | Fate Therapeutics, Inc. | Combining iPSC-derived effector cell types for immunotherapy use |
| CN114525255A (zh) * | 2020-10-30 | 2022-05-24 | 未来智人再生医学研究院(广州)有限公司 | 一种表达il-11的多能干细胞衍生物及其应用 |
| CA3196549A1 (en) * | 2020-11-04 | 2022-05-12 | Bahram Valamehr | Engineered ipsc and immune effector cells for heterogenous tumor control |
| JP2023548467A (ja) * | 2020-11-04 | 2023-11-17 | フェイト セラピューティクス，インコーポレイティド | 操作されたｉＰＳＣ及び持続性免疫エフェクター細胞 |
| US11591381B2 (en) | 2020-11-30 | 2023-02-28 | Crispr Therapeutics Ag | Gene-edited natural killer cells |
| AU2021392032A1 (en) | 2020-12-03 | 2023-06-22 | Century Therapeutics, Inc. | Genetically engineered cells and uses thereof |
| US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
| AR124414A1 (es) | 2020-12-18 | 2023-03-22 | Century Therapeutics Inc | Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable |
| WO2022144632A1 (en) | 2020-12-30 | 2022-07-07 | Crispr Therapeutics Ag | Compositions and methods for differentiating stem cells into nk cells |
| CA3204417A1 (en) * | 2021-01-29 | 2022-08-04 | Allogene Therapeutics, Inc. | Knockdown or knockout of one or more of tap2, nlrc5, ?2m, trac, rfx5, rfxap and rfxank to mitigate t cell recognition of allogeneic cell products |
| CN117615781A (zh) * | 2021-02-25 | 2024-02-27 | 克莱格医学有限公司 | Cd94工程化细胞及其组合物 |
| US20220333074A1 (en) * | 2021-04-07 | 2022-10-20 | Century Therapeutics, Inc. | Compositions and Methods for Generating Alpha-Beta T Cells from Induced Pluripotent Stem Cells |
| JP2024522756A (ja) * | 2021-06-18 | 2024-06-21 | オーエヌケイ セラピューティクス リミテッド | ダブルノックアウトナチュラルキラー細胞 |
| CN118284686A (zh) * | 2021-11-24 | 2024-07-02 | 杭州启函生物科技有限公司 | 用于基于细胞的免疫疗法的系统和方法 |
| EP4353741A1 (en) * | 2022-10-14 | 2024-04-17 | ONK Therapeutics Limited | Double knockout natural killer cells |
| WO2024183750A1 (en) * | 2023-03-07 | 2024-09-12 | Qihan Hong Kong Limited | A novel immune cell and use thereof for treating diseases |
| WO2025189046A2 (en) * | 2024-03-06 | 2025-09-12 | The Johns Hopkins University | Pantigen specific cytokine receptor stimulation of immune cell function |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9710807D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| GB9710809D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| GB9725764D0 (en) * | 1997-12-04 | 1998-02-04 | Isis Innovation | HLA-E binding |
| US6140081A (en) | 1998-10-16 | 2000-10-31 | The Scripps Research Institute | Zinc finger binding domains for GNN |
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| JP2002060786A (ja) | 2000-08-23 | 2002-02-26 | Kao Corp | 硬質表面用殺菌防汚剤 |
| US20040224385A1 (en) | 2001-08-20 | 2004-11-11 | Barbas Carlos F | Zinc finger binding domains for cnn |
| US7745140B2 (en) | 2002-01-03 | 2010-06-29 | The Trustees Of The University Of Pennsylvania | Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool |
| US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US7972854B2 (en) | 2004-02-05 | 2011-07-05 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| AU2005250408B2 (en) | 2004-05-27 | 2010-09-23 | The Trustees Of The University Of Pennsylvania | Novel artificial antigen presenting cells and uses therefor |
| WO2007146968A2 (en) | 2006-06-12 | 2007-12-21 | Trubion Pharmaceuticals, Inc. | Single-chain multivalent binding proteins with effector function |
| JP5368301B2 (ja) | 2006-06-22 | 2013-12-18 | ノボ・ノルデイスク・エー／エス | 可溶性ヘテロ二量体レセプター及びその使用 |
| HUE041436T2 (hu) | 2009-12-10 | 2019-05-28 | Univ Minnesota | Tal-effektor-közvetített DNS-módosítás |
| EP3399026B1 (en) | 2010-06-14 | 2024-06-26 | The Scripps Research Institute | Reprogramming of cells to a new fate |
| EP3549611B1 (en) | 2011-07-29 | 2021-06-30 | The Trustees of the University of Pennsylvania | Switch costimulatory receptors |
| JP6850528B2 (ja) | 2012-02-13 | 2021-03-31 | シアトル チルドレンズ ホスピタル ドゥーイング ビジネス アズ シアトル チルドレンズ リサーチ インスティテュート | 二重特異性キメラ抗原受容体およびその治療的使用 |
| KR102437522B1 (ko) | 2012-05-25 | 2022-08-26 | 셀렉티스 | 면역요법을 위한 동종이형 및 면역억제제 저항성인 ｔ 세포의 조작 방법 |
| EP4303232A3 (en) | 2013-02-15 | 2024-04-17 | The Regents of The University of California | Chimeric antigen receptor and methods of use thereof |
| US9932607B2 (en) | 2013-11-15 | 2018-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Site-specific integration of transgenes into human cells |
| US10934346B2 (en) | 2014-02-14 | 2021-03-02 | Bellicum Pharmaceuticals, Inc. | Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12 |
| EP3656864A1 (en) | 2014-02-14 | 2020-05-27 | Board of Regents, The University of Texas System | Chimeric antigen receptors and methods of making |
| SG11201606934SA (en) | 2014-03-04 | 2016-09-29 | Fate Therapeutics Inc | Improved reprogramming methods and cell culture platforms |
| CN113699159A (zh) | 2014-03-28 | 2021-11-26 | 明尼苏达大学评议会 | 涉及经工程改造的cd16的多肽、细胞和方法 |
| US10888608B2 (en) | 2014-09-02 | 2021-01-12 | Bellicum Pharmaceuticals, Inc. | Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides |
| SG10202111851YA (en) | 2015-10-16 | 2021-12-30 | Fate Therapeutics Inc | Platform for the Induction & Maintenance of Ground State Pluripotency |
| CA3003152A1 (en) | 2015-11-04 | 2017-05-11 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| JP2019506143A (ja) | 2015-12-14 | 2019-03-07 | ベリカム ファーマシューティカルズ， インコーポレイテッド | 治療用細胞の活性化及び排除のための二重コントロール |
| CA3010236A1 (en) * | 2016-01-20 | 2017-07-27 | Fate Therapeutics, Inc. | Compositions and methods for immune cell modulation in adoptive immunotherapies |
| CA3083779A1 (en) | 2017-12-22 | 2019-06-27 | Fate Therapeutics, Inc. | Enhanced immune effector cells and use thereof |
-
2019
- 2019-11-25 KR KR1020217019117A patent/KR102943217B1/ko active Active
- 2019-11-25 US US17/297,805 patent/US12435123B2/en active Active
- 2019-11-25 MX MX2021006194A patent/MX2021006194A/es unknown
- 2019-11-25 CN CN201980079481.0A patent/CN113166232A/zh active Pending
- 2019-11-25 SG SG11202105480WA patent/SG11202105480WA/en unknown
- 2019-11-25 BR BR112021010331-7A patent/BR112021010331A2/pt unknown
- 2019-11-25 WO PCT/US2019/063024 patent/WO2020117526A1/en not_active Ceased
- 2019-11-25 CA CA3121128A patent/CA3121128A1/en active Pending
- 2019-11-25 EP EP19893181.8A patent/EP3891177A4/en active Pending
- 2019-11-25 JP JP2021530163A patent/JP2022510207A/ja active Pending
- 2019-11-25 AU AU2019392265A patent/AU2019392265A1/en active Pending
-
2021
- 2021-06-01 IL IL283607A patent/IL283607A/en unknown
-
2025
- 2025-02-06 JP JP2025018442A patent/JP2025072543A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021505131A5 (https=) | ||
| US20260055157A1 (en) | Methods of making chimeric antigen receptor-expressing cells | |
| Zhang et al. | Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside | |
| US20220380461A1 (en) | Transgene genetic tags and methods of use | |
| JPWO2021011919A5 (https=) | ||
| KR102763121B1 (ko) | 치료적 면역 세포의 효능의 향상 방법 | |
| JP2021519061A5 (https=) | ||
| JP2022169574A (ja) | 最適化されたレンチウイルス移入ベクターおよびその使用 | |
| JPWO2020117526A5 (https=) | ||
| JPWO2021071962A5 (https=) | ||
| CN111787938A (zh) | 靶向bcma的嵌合抗原受体、靶向cd19的嵌合抗原受体及组合疗法 | |
| JPWO2021062281A5 (https=) | ||
| RS62870B1 (sr) | Himerni antigenski receptori sa ciljanim delovanjem na receptore spregnute sa g-proteinom i njihove upotrebe | |
| EP3490590A2 (en) | Treatment of cancer using a chimeric antigen receptor in combination with an inhibitor of a pro-m2 macrophage molecule | |
| JP2024502157A (ja) | 樹状細胞活性化キメラ抗原受容体及びその使用 | |
| JPWO2019191495A5 (https=) | ||
| WO2018111340A1 (en) | Methods for determining potency and proliferative function of chimeric antigen receptor (car)-t cells | |
| CN114163532A (zh) | 包含新型共刺激结构域的嵌合抗原受体及其用途 | |
| US12203098B2 (en) | Cells having solid tumor targeting backbone and use thereof | |
| JPWO2021113744A5 (https=) | ||
| JPWO2021258016A5 (https=) | ||
| EP4126016A1 (en) | Augmenting antigen-negative cell death in antigen-targeted immunotherapies | |
| JPWO2022098914A5 (https=) | ||
| JPWO2022098925A5 (https=) | ||
| CN115785279A (zh) | 包含新型共刺激结构域的嵌合抗原受体及其用途 |